Initial UK experience of patient satisfaction with the Meniett® device for Ménière's disease treatment.
OBJECTIVE
To evaluate patient satisfaction and symptom improvement following treatment of Ménière's disease with the Meniett® device.


METHODS
Retrospective, questionnaire-based audit and analysis of unilateral Ménière's disease patients' records, following on from a previous study from our departments on intra-tympanic gentamicin for Ménière's disease, using the Vertigo Symptom Scale and Glasgow Benefit Inventory as outcome measures.


RESULTS
Of 33 consecutive patients treated with the Meniett® device for four to six weeks, 30 responded to the questionnaires (90.9 per cent). Respondents' mean Vertigo Symptom Scale score was 0.7 (range 0-2.1), and their mean Glasgow Benefit Inventory general subscale score was 24.1. Nineteen (63.3 per cent) patients felt that the device had alleviated their vertigo and tinnitus.


CONCLUSIONS
This is the first UK study of the effectiveness of the Meniett® device in treating Ménière's disease. It shows that the Meniett® device is a well tolerated, useful and minimally invasive means of treating Ménière's disease after medical treatment has failed, and before more potentially cochleo- and vestibulo-toxic therapies and invasive procedures are utilised.
Buchanan
M A
MA
Departments of Otolaryngology, Norfolk and Norwich University Hospital, Great Yarmouth, UK. malcolm_buchanan123@hotmail.com
Rai
A
A
Prinsley
P R
PR
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004712:Endolymphatic Sac / Q000503:physiopathology; D004867:Equipment Design; D005260:Female; D006319:Hearing Loss, Sensorineural / Q000534:rehabilitation; D006801:Humans; D008297:Male; D008485:Medical Audit; D008575:Meniere Disease / Q000503:physiopathology / Q000628:therapy*; D008875:Middle Aged; D008876:Middle Ear Ventilation; D017063:Outcome Assessment, Health Care; D017060:Patient Satisfaction; D026741:Physical Therapy Modalities / Q000295:instrumentation; D011312:Pressure; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic; D014012:Tinnitus / Q000209:etiology / Q000628:therapy; D017211:Treatment Failure; D006113:United Kingdom; D014717:Vertigo / Q000209:etiology / Q000628:therapy